185 related articles for article (PubMed ID: 24612464)
1. Analysis of lymphatic and blood vessel invasion biomarkers in T1 esophagogastric adenocarcinomas for improved patient prognostication.
Perry C; Soomro I; Kaye P; Hardy E; Parsons SL; Ragunath K; Lobo DN; Martin SG; Madhusudan S
Dis Esophagus; 2015 Apr; 28(3):262-8. PubMed ID: 24612464
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of immunohistochemically detected blood and lymphatic vessel invasion in colorectal carcinoma: its impact on prognosis.
Liang P; Nakada I; Hong JW; Tabuchi T; Motohashi G; Takemura A; Nakachi T; Kasuga T; Tabuchi T
Ann Surg Oncol; 2007 Feb; 14(2):470-7. PubMed ID: 17103258
[TBL] [Abstract][Full Text] [Related]
3. Detection of lymphovascular invasion by D2-40 (podoplanin) immunoexpression in endometrial cancer.
Weber SK; Sauerwald A; Pölcher M; Braun M; Debald M; Serce NB; Kuhn W; Brunagel-Walgenbach G; Rudlowski C
Int J Gynecol Cancer; 2012 Oct; 22(8):1442-8. PubMed ID: 22964524
[TBL] [Abstract][Full Text] [Related]
4. Improved methods of detection of lymphovascular invasion demonstrate that it is the predominant method of vascular invasion in breast cancer and has important clinical consequences.
Mohammed RA; Martin SG; Gill MS; Green AR; Paish EC; Ellis IO
Am J Surg Pathol; 2007 Dec; 31(12):1825-33. PubMed ID: 18043036
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical assessment of lymphatic and blood vessel invasion in T1 urothelial carcinoma of the bladder.
Gakis G; Todenhöfer T; Braun M; Fend F; Stenzl A; Perner S
Scand J Urol; 2015; 49(5):382-7. PubMed ID: 25921278
[TBL] [Abstract][Full Text] [Related]
6. Significance of pathological evaluation for lymphatic vessel invasion in invasive breast cancer.
Ito M; Moriya T; Ishida T; Usami S; Kasajima A; Sasano H; Ohuchi N
Breast Cancer; 2007; 14(4):381-7. PubMed ID: 17986803
[TBL] [Abstract][Full Text] [Related]
7. Lymphatic vessel invasion as a prognostic factor in patients with primary resected adenocarcinomas of the esophagogastric junction.
von Rahden BH; Stein HJ; Feith M; Becker K; Siewert JR
J Clin Oncol; 2005 Feb; 23(4):874-9. PubMed ID: 15681533
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical evaluation of lymphovascular invasion in carcinoma breast with CD34 and D2-40 and its correlation with other prognostic markers.
Agarwal S; Singh A; Bagga PK
Indian J Pathol Microbiol; 2018; 61(1):39-44. PubMed ID: 29567882
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of vascular invasion and standardization of its evaluation in stage I non-small cell lung cancer.
Hamanaka R; Yokose T; Sakuma Y; Tsuboi M; Ito H; Nakayama H; Yamada K; Masuda R; Iwazaki M
Diagn Pathol; 2015 Apr; 10():17. PubMed ID: 25884820
[TBL] [Abstract][Full Text] [Related]
10. Lymphovascular invasion in more than one-quarter of small rectal neuroendocrine tumors.
Kwon MJ; Kang HS; Soh JS; Lim H; Kim JH; Park CK; Park HR; Nam ES
World J Gastroenterol; 2016 Nov; 22(42):9400-9410. PubMed ID: 27895428
[TBL] [Abstract][Full Text] [Related]
11. Lymphovascular invasion as a tool to further subclassify T1b esophageal adenocarcinoma.
Cen P; Hofstetter WL; Correa AM; Wu TT; Lee JH; Ross WA; Davilla M; Swisher SG; Fukami N; Rashid A; Maru D; Ajani JA
Cancer; 2008 Mar; 112(5):1020-7. PubMed ID: 18205187
[TBL] [Abstract][Full Text] [Related]
12. Significance of lymphangiogenesis as assessed by immunohistochemistry for podoplanin in patients with esophageal carcinoma.
Nakayama Y; Matsumoto K; Nagato M; Inoue Y; Katsuki T; Minagawa N; Shibao K; Tsurudome Y; Hirata K; Higure A; Sako T; Nagata N
Anticancer Res; 2007; 27(1B):619-25. PubMed ID: 17348451
[TBL] [Abstract][Full Text] [Related]
13. Duplicated muscularis mucosae invasion has similar risk of lymph node metastasis and recurrence-free survival as intramucosal esophageal adenocarcinoma.
Estrella JS; Hofstetter WL; Correa AM; Swisher SG; Ajani JA; Lee JH; Bhutani MS; Abraham SC; Rashid A; Maru DM
Am J Surg Pathol; 2011 Jul; 35(7):1045-53. PubMed ID: 21602659
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathology significance of podoplanin immunoreactivity in esophageal squamous cell carcinoma.
Ma W; Wang K; Yang S; Wang J; Tan B; Bai B; Wang N; Jia Y; Jia M; Cheng Y
Int J Clin Exp Pathol; 2014; 7(5):2361-71. PubMed ID: 24966946
[TBL] [Abstract][Full Text] [Related]
15. Lymphatic and/or blood vessel invasion in gastric cancer: relationship with clinicopathological parameters, biological factors and prognostic significance.
del Casar JM; Corte MD; Alvarez A; García I; Bongera M; González LO; García-Muñiz JL; Allende MT; Astudillo A; Vizoso FJ
J Cancer Res Clin Oncol; 2008 Feb; 134(2):153-61. PubMed ID: 17628829
[TBL] [Abstract][Full Text] [Related]
16. Lymphatic vessel invasion detected by the endothelial lymphatic marker D2-40 (podoplanin) is predictive of regional lymph node status and an independent prognostic factor in patients with resected esophageal cancer.
Kozłowski M; Naumnik W; Nikliński J; Milewski R; Lapuć G; Laudański J
Folia Histochem Cytobiol; 2011; 49(1):90-7. PubMed ID: 21526494
[TBL] [Abstract][Full Text] [Related]
17. Lymphatic vessel invasion detected by the D2-40 monoclonal antibody is an independent prognostic factor in node-negative esophageal squamous cell carcinoma.
Imamura Y; Watanabe M; Nagai Y; Baba Y; Hirashima K; Karashima R; Iwatsuki M; Yoshida N; Kinoshita K; Kurashige J; Iyama K; Baba H
J Surg Oncol; 2012 Mar; 105(3):277-83. PubMed ID: 22271500
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of detecting lymphatic and blood vessel invasion in stage II colon cancer using markers D2-40 and CD34 in combination.
Lai JH; Zhou YJ; Bin D; Qiangchen ; Wang SY
Asian Pac J Cancer Prev; 2014; 15(3):1363-7. PubMed ID: 24606466
[TBL] [Abstract][Full Text] [Related]
19. Lymphangiogenesis and lymphovascular invasion diminishes prognosis in esophageal cancer.
Schoppmann SF; Jesch B; Zacherl J; Riegler MF; Friedrich J; Birner P
Surgery; 2013 Apr; 153(4):526-34. PubMed ID: 23294880
[TBL] [Abstract][Full Text] [Related]
20. Detection of lymphovascular invasion in vulvar cancer by D2-40 (podoplanin) as a predictor for inguinal lymph node metastases.
Braun M; Wardelmann E; Debald M; Walgenbach-Bruenagel G; Höller T; Wolfgarten M; Sauerwald A; Rudlowski C; Büttner R; Kuhn W; Pölcher M
Onkologie; 2009 Dec; 32(12):732-8. PubMed ID: 20016234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
